MannKind Provides Business Updates and 2026 Growth Drivers…
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for cardiomet… [5099 chars]
Source: GlobeNewswire | Published: 2026-01-08T13:05:00Z
Credit: GlobeNewswire
